RT Book, Section
A1 Bissonnette, Bruno
A1 Luginbuehl, Igor
A1 Engelhardt, Thomas
SR Print(0)
ID 1164078784
T1 Miller Fisher Syndrome
T2 Syndromes: Rapid Recognition and Perioperative Implications, 2e
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9781259861789
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1164078784
RD 2024/04/19
AB It  is  a  rare  and  acquired  nerve  disease  considered  to  be  a  variant  of  the  Guillain-Barré  Syndrome.  It  is  characterized  by  abnormal  muscle  coordination,  ophthalmoplegia,  and  tendon  areflexia.  As  with  Guillain-Barré  Syndrome,  the  symptoms  may  be  preceded  by  a  viral  illness.  Other  clinical  features  include  generalized  muscle  weakness  and  respiratory  failure.  The  prognosis  is  good,  with  recovery  beginning  within  2  to  4  weeks  and  almost  completed  within  6  months.  Residual  neurologic  deficits  may  occur,  and  relapses  occur  in  less  than  3%  of  individuals  affected.  The  majority  of  individuals  with  Miller  Fisher  Syndrome  have  a  unique  antibody  that  characterizes  the  disorder.